Scott A. Hammond

6.2k total citations · 2 hit papers
82 papers, 3.8k citations indexed

About

Scott A. Hammond is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Scott A. Hammond has authored 82 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Immunology, 36 papers in Oncology and 22 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Scott A. Hammond's work include Immunotherapy and Immune Responses (30 papers), Cancer Immunotherapy and Biomarkers (24 papers) and Immune Cell Function and Interaction (24 papers). Scott A. Hammond is often cited by papers focused on Immunotherapy and Immune Responses (30 papers), Cancer Immunotherapy and Biomarkers (24 papers) and Immune Cell Function and Interaction (24 papers). Scott A. Hammond collaborates with scholars based in United States, France and United Kingdom. Scott A. Hammond's co-authors include Gregory M. Glenn, Ronald C. Montelaro, Robert F. Siliciano, Marie‐Caroline Dieu‐Nosjean, Diane Damotte, Larry Ellingsworth, Jérémy Goc, Sheila J. Cook, Wolf H. Fridman and Catherine Sautès‐Fridman and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Scott A. Hammond

74 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dendritic Cells in Tumor-Associated Tertiary Lymphoid Structures Signal a Th1 Cytotoxic Immune Contexture and License the Positive Prognostic Value of Infiltrating CD8+ T Cells

2013 500 citations Jérémy Goc, Claire Germain et al. Cancer Research profile →
Androgen receptor activity in T cells limits checkpoint blockade efficacy

2022 233 citations Scott A. Hammond et al. profile →

Peers

Countries citing papers authored by Scott A. Hammond

Since Specialization

Citations

This map shows the geographic impact of Scott A. Hammond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott A. Hammond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott A. Hammond more than expected).

Fields of papers citing papers by Scott A. Hammond

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott A. Hammond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott A. Hammond. The network helps show where Scott A. Hammond may publish in the future.

Co-authorship network of co-authors of Scott A. Hammond

This figure shows the co-authorship network connecting the top 25 collaborators of Scott A. Hammond. A scholar is included among the top collaborators of Scott A. Hammond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott A. Hammond. Scott A. Hammond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In Vivo Labeling Resolves Distinct Temporal, Spatial, and Functional Properties of Tumor Macrophages and Identifies Subset-Specific Effects of PD-L1 Blockade 2025 ·Cancer Immunology Research ·Colin Y.C. Lee, Isaac Dean, Nathan Richoz, Zhi Li, (unknown), Lisa A. Vettore, (unknown), Kathryn Gilroy, Tetsuo Hasegawa, Gianluca Carlesso, Scott A. Hammond, Simon J. Dovedi, Owen J. Sansom, Zewen Kelvin Tuong, Timotheus Y.F. Halim, David R. Withers, Menna R. Clatworthy	0
2	Artificial intelligence algorithm accurately assesses oestrogen receptor immunohistochemistry in metastatic breast cancer cytology specimens: A pilot study 2024 ·Cytopathology ·(unknown), Scott A. Hammond, Anil V. Parwani, Rulong Shen	1
3	Comparison of four different displays for identification of select pathologic features extracted from whole slide images of surgical pathology cases 2023 ·Pathology - Research and Practice ·(unknown), Konstantin Shilo, Ashwini Esnakula, Saba Shafi, (unknown), Ankush Patel, (unknown), Scott A. Hammond, (unknown), Swati Satturwar, Martha Yearsley, Zaibo Li, (unknown), Giovanni Lujan, Anil V. Parwani	1
4	Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors 2022 ·Clinical Cancer Research ·Jonathan W. Goldman, Sarina A. Piha‐Paul, Brendan D. Curti, Katrina S. Pedersen, Todd M. Bauer, Stefanie L. Groenland, Richard D. Carvajal, (unknown), (unknown), Kelly McGlinchey, Scott A. Hammond, Katie Streicher, Danielle M. Townsley, Young Kwang Chae, Jens Voortman, Aurélien Marabelle, John D. Powderly	19
5	In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue 2022 ·The Journal of Experimental Medicine ·Zhi Li, Zewen Kelvin Tuong, Isaac Dean, Claire Willis, Fabrina Gaspal, Rémi Fiancette, (unknown), (unknown), John R. Ferdinand, Ana Peñalver, (unknown), Syed Murtuza Baker, Jeremy Fry, Gianluca Carlesso, Scott A. Hammond, Simon J. Dovedi, Matthew R. Hepworth, Menna R. Clatworthy, David R. Withers	63
6	469 Preclinical studies support clinical development of AZD2936, a monovalent bispecific humanized antibody targeting PD-1 and TIGIT 2022 ·Regular and Young Investigator Award Abstracts ·(unknown), Deepali Malhotra, (unknown), Eleanor Clancy‐Thompson, Bilal Omar, Brian Naiman, Michael G. Overstreet, Devon K. Taylor, (unknown), Kathy Mulgrew, (unknown), Yue Wang, Gordon Moody, Mark Cobbold, Yariv Mazor, Scott A. Hammond, Kristen Pollizzi	5
7	Chemoradiotherapy efficacy is predicted by intra-tumour CD8+/FoxP3+ double positive T cell density in locally advanced N2 non–small-cell lung carcinoma 2020 ·European Journal of Cancer ·(unknown), (unknown), Audrey Mansuet‐Lupo, Laure Gibault, Hélène Blons, Ludovic Fournel, (unknown), Isabelle Cremer, Marie Wislez, Véronique Duchatelle, Jean Trédaniel, Scott A. Hammond, Roy S. Herbst, Marco Alifano, P. Giraud, Diane Damotte	16
8	A Validation Study of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry Digital Imaging Analysis and its Correlation with Human Epidermal Growth Factor Receptor 2 Fluorescence In situ Hybridization Results in Breast Carcinoma 2020 ·Journal of Pathology Informatics ·(unknown), (unknown), Scott A. Hammond, Anil V. Parwani	21
9	Concurrent PD-1 Blockade Negates the Effects of OX40 Agonist Antibody in Combination Immunotherapy through Inducing T-cell Apoptosis 2017 ·Cancer Immunology Research ·Rajeev Shrimali, Shamim Ahmad, Vivek Verma, Peng Zeng, Sudha Ananth, Pankaj Gaur, Rachel M. Gittelman, Erik Yusko, Catherine Sanders, Harlan Robins, Scott A. Hammond, John E. Janik, Mikayel Mkrtichyan, Seema Gupta, Samir N. Khleif	117
10	Carbohydrate mouth rinse improves morning high‐intensity exercise performance 2017 ·European Journal of Sport Science ·Neil D. Clarke, Scott A. Hammond, (unknown), Peter Mundy	24
11	CEA/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomas 2014 ·mAbs ·Michael D. Oberst, Stacy Fuhrmann, Kathy Mulgrew, Maria Amann, Lily Cheng, Petra Lutterbuese, Laura K. Richman, Steve Coats, Patrick A. Baeuerle, Scott A. Hammond	71
12	Dendritic Cells in Tumor-Associated Tertiary Lymphoid Structures Signal a Th1 Cytotoxic Immune Contexture and License the Positive Prognostic Value of Infiltrating CD8+ T Cells breakdown → 2013 ·Cancer Research ·Jérémy Goc, Claire Germain, Thi Kim Duy Vo-Bourgais, Audrey Lupo, Christophe Klein, Samantha Knockaert, Luc de Chaisemartin, Hanane Ouakrim, Étienne Becht, Marco Alifano, Pierre Validire, Romain Remark, Scott A. Hammond, Isabelle Cremer, Diane Damotte, Wolf H. Fridman, Catherine Sautès‐Fridman, Marie‐Caroline Dieu‐Nosjean	500
13	Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody 2009 ·British Journal of Cancer ·Takuya Osada, David S. Hsu, Scott A. Hammond, Amy Hobeika, Gayathri R. Devi, Timothy M. Clay, H. Kim Lyerly, Michael A. Morse	61
14	Bioavailability, pharmacodynamic activity, and anti-tumor efficacy of the CD19/CD3-specific BiTE antibody MEDI-538 (MT103) delivered subcutaneously in animal models 2008 ·Cancer Research ·Kathy Mulgrew, David J. Stewart, (unknown), Wendy L. Trigona, Patricia C. Ryan, (unknown), Ambarish Shah, (unknown), Liang Zhao, Stacy Fuhrmann, Philipp Steiner, Gabriel J. Robbie, Petra Lutterbuese, Bernd Schlereth, Patrick A. Baeuerle, Peter Kufer, Peter A. Kiener, Bahija Jallal, Steven Coats, Scott A. Hammond	2
15	Selective Targeting and Potent Control of Tumor Growth Using an EphA2/CD3-Bispecific Single-Chain Antibody Construct 2007 ·Cancer Research ·Scott A. Hammond, Ralf Lutterbuese, Shannon Roff, Petra Lutterbuese, Bernd Schlereth, Elizabeth Bruckheimer, Michael S. Kinch, Steve Coats, Patrick A. Baeuerle, Peter Kufer, Peter A. Kiener	66
16	Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells 2004 ·Journal of Clinical Investigation ·Igor M. Belyakov, Scott A. Hammond, Jeffrey D. Ahlers, Gregory M. Glenn, Jay A. Berzofsky	7
17	Transcutaneous immunization and immunostimulant strategies 2003 ·Immunology and Allergy Clinics of North America ·Gregory M. Glenn, Richard T. Kenney, Scott A. Hammond, Larry Ellingsworth	38
18	Multiple RNA splicing and the presence of cryptic RNA splice donor and acceptor sites may contribute to low expression levels and poor immunogenicity of potential DNA vaccines containing the env gene of equine infectious anemia virus (EIAV) 2002 ·Veterinary Microbiology ·Weisong Zhou, R. Frank Cook, Sheila J. Cook, Scott A. Hammond, Keith E. Rushlow, (unknown), (unknown), Ronald C. Montelaro, C. J. Issel	7
19	Cytokines from Vaccine-Induced HIV-1 Specific Cytotoxic T Lymphocytes: Effects on Viral Replication 1993 ·AIDS Research and Human Retroviruses ·Robert C. Bollinger, Thomas C. Quinn, Alice Y.‐C. Liu, P E Stanhope, Scott A. Hammond, (unknown), M L Clements, Robert F. Siliciano	20
20	Clonal Analysis of T-Cell Responses to the HIV-1 Envelope Proteins in AIDS Vaccine Recipients 1992 ·AIDS Research and Human Retroviruses ·Robert F. Siliciano, Robert C. Bollinger, (unknown), Scott A. Hammond, Alice Y.‐C. Liu, Emil Miskovsky, J F Rowell, P E Stanhope	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact